Myofibroblast

Histology for Pathologists: Fourth Edition

Volumn , Issue , 2012, Pages

  Hinz, Boris ^a   Gabbiani, Giulio ^b   Seemayer, Thomas A ^c   Schürch, Walter ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84961632167     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (385)

1. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971;27:549-550.
2. Majno G, Gabbiani G, Hirschel BJ, et al. Contraction of granulation tissue in vitro: Similarity to smooth muscle. Science 1971;173:548-550.
3. Gabbiani G, Hirschel BJ, Ryan GB, et al. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 1972;135:719-734.
4. Hirschel BJ, Gabbiani G, Ryan GB, et al. Fibroblasts of granulation tissue: Immunofluorescent staining with antismooth muscle serum. Proc Soc Exp Biol Med 1971;138:466-469.
5. Gabbiani G, Ryan GB, Lamelin JP, et al. Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol 1973;72:473-488.
6. Seemayer TA, Lagacé R, Schürch W, et al. The myofibroblast: Biologic, pathologic, and theoretical considerations. Pathol Annu 1980;15:443-470.
7. Hinz B, Gabbiani G. Fibrosis: Recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biology Reports 2010;2:78-82.
8. Hinz B, Phan SH, Thannickal VJ, et al. The myofibroblast: One function, multiple origins. Am J Pathol 2007;170:1807-1816.
9. Majno G. The story of the myofibroblasts. Am J Surg Pathol 1979;3:535-542.
10. Majno G. The Healing Hand: Man and Wound in the Ancient World. Cambridge: Harvard University Press; 1975.
11. Carrel A, Hartmann A, Cicatrization of Wounds: I. The Relation between the Size of a Wound and the Rate of Its Cicatrization. J Exp Med 1916;24:429-450.
12. Abercrombie M, Flint MH, James DW. Wound contraction in relation to collagen formation in scorbutic guinea pigs. J Embryol Exp Morphol 1956;4:167-175.
13. Hoffmann-Berling H. Adenosinetriphosphate as the energy substance for cell movement. Biochim Biophys Acta 1954;14:182-194.
14. Majno G, Shea SM, Leventhal M. Endothelial contraction induced by histamine-type mediators: An electron microscopic study. J Cell Biol 1969;42:647-672.
15. Gabbiani G. Curr Contents: Citation Classics. 1988;31:16.
16. Gabbiani G, Majno G. Dupuytren's contracture: Fibroblast contraction? An ultrastructural study. Am J Pathol 1972;66:131-146.
17. Ryan GB, Cliff WJ, Gabbiani G, et al. Myofibroblasts in human granulation tissue. Hum Pathol 1974;5:55-67.
18. Gabbiani G, Chaponnier C, Hüttner I. Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during wound healing. J Cell Biol 1978;76:561-568.
19. Singer II, Kawka DW, Kazazis DM, et al. In vivo co-distribution of fibronectin and actin fibers in granulation tissue: Immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol 1984;98:2091-2106.
20. Tremblay G. Stromal aspects of breast carcinoma. Exp Mol Pathol 1979;31:248-260.
21. Seemayer TA, Lagacé R, Schürch W, et al. Myofibroblasts in the stroma of invasive and metastatic carcinoma: A possible host response to neoplasia. Am J Surg Pathol 1979;3:525-533.
22. Schürch W, Seemayer TA, Lagacé R. Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light and electron microscopic study. Virchows Arch A Pathol Anat Histol 1981;391:125-139.
23. Schürch W, Lagacé R, Seemayer TA. Myofibroblastic stromal reaction in retracted scirrhous carcinoma of the breast. Surg Gynecol Obstet 1982;154:351-358.
24. Skalli O, Schürch W, Seemayer T, et al. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989;60:275-285.
25. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-29.
26. Schürch W, Skalli O, Gabbiani G. Cellular biology of Dupuytren's disease. In: McFarlane RM, McGrouther DA, Flint MH, eds. Dupuytren's Disease. London: Churchill Livingstone; 1990:31-47.
27. Hinz B, Mastrangelo D, Iselin CE, et al. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001;159:1009-1020.
28. Hinz B, Celetta G, Tomasek JJ, et al. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001;12:2730-2741.
29. Hinz B, Gabbiani G, Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol 2002;157:657-663.
30. Wang J, Zohar R, McCulloch CA. Multiple roles of alpha-smooth muscle actin in mechanotransduction. Exp Cell Res 2006;312:205-214.
31. Hinz B. The myofibroblast: Paradigm for a mechanically active cell. J Biomech 2010;43:146-155.
32. Goffin JM, Pittet P, Csucs G, et al. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J Cell Biol 2006;172:259-268.
33. Wipff PJ, Rifkin DB, Meister JJ, et al. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007;179:1311-1323.
34. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999;154:871-882.
35. Desmoulière A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-111.
36. Rønnov-Jessen L, Petersen OW. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 1993;68:696-707.
37. Zhang K, Rekhter MD, Gordon D, et al. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994;145:114-125.
38. Serini G, Bochaton-Piallat ML, Ropraz P, et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998;142:873-881.
39. Desmoulière A, Redard M, Darby I, et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
40. Friedman SL. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004;1:98-105.
41. Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991;87:847-858.
42. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003;112:1776-1784.
43. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003;348:403-413.
44. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
45. Yang L, Scott PG, Giuffre J, et al. Peripheral blood fibrocytes from burn patients: Identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002;82:1183-1192.
46. Gabella G. Structural apparatus for force transmission in smooth muscles. Physiol Rev 1984;64:455-477.
47. Hüttner I, Kocher O, Gabbiani G. Endothelial and smooth muscle cells. In: Camilleri JP, Berry CL, Fiessinger JN, Bariety J, eds. Diseases of the Arterial Wall. New York, NY: Springer-Verlag; 1989:3-41.
48. Schollmeyer JE, Furcht LT, Goll DE, et al. Localization of contractile proteins in smooth muscle cells and in normal and transformed fibroblsts. In: Goldman R, Pollard T, Rosenbaum J, eds. Cell Motility. Cold Spring Harbor, NY: Cold Spring harbor Laboratory, 1976:361-388.
49. Medalia O, Geiger B. Frontiers of microscopy-based research into cell-matrix adhesions. Curr Opin Cell Biol 2010;22:659-668.
50. Hinz B, Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: Role in connective tissue remodeling. Thromb Haemost 2003;90:993-1002.
51. Hinz B, Pittet P, Smith-Clerc J, et al. Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol Biol Cell 2004;15:4310-4320.
52. Singer II. The fibronexus: A transmembrane association of fibronectin-containing fibers and bundles of 5 nm microfilaments in hamster and human fibroblasts. Cell 1979;16:675-685.
53. Schürch W, Seemayer TA, Gabbiani G. The myofibroblast: A quarter century after its discovery. Am J Surg Pathol 1998;22:141-147.
54. Eyden B. The fibronexus in reactive and tumoral myofibroblasts: Further characterisation by electron microscopy. Histol Histopathol 2001;16:57-70.
55. Weiss SW, Goldblum JR, Enzinger FM. Fibrosarcoma. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. St. Louis, MO: Mosby; 2001:416.
56. Erlandson RA. Role of Electron Microscopy in Modern Diagnostic Surgical Pathology. In: Weidner N, Cote RJ, Suster S, Weiss LM, eds. Modern Surgical Pathology. Philadelphia, PA: WB Saunders; 2003:83.
57. Rosai J. Rosai and Ackerman's Surgical Pathology. St Louis, Missouri: Mosby; 2004.
58. Caplan AI, Fiszman MY, Eppenberger HM. Molecular and cell isoforms during development. Science 1983;221:921-927.
59. Schürch W, Skalli O, Seemayer TA, et al. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors. Am J Pathol 1987;128:91-103.
60. Schürch W, Skalli O, Lagacé R, et al. Intermediate filament proteins and actin isoforms as markers for soft- tissue tumor differentiation and origin. III. Hemangiopericytomas and glomus tumors. Am J Pathol 1990;136:771-786.
61. Babaï F, Skalli O, Schürch W, et al. Chemically induced rhabdomyosarcomas in rats. Ultrastructural, immunohistochemical, biochemical features and expression of alpha-actin isoforms. Virchows Arch B Cell Pathol Incl Mol Pathol 1988;55:263-277.
62. Benzonana G, Skalli O, Gabbiani G. Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues. Cell Motil Cytoskeleton 1988;11:260-274.
63. Larson DM, Fujiwara K, Alexander RW, et al. Myosin in cultured vascular smooth muscle cells: immunofluorescence and immunochemical studies of alterations in antigenic expression. J Cell Biol 1984;99:1582-1589.
64. Gabbiani G, Schmid E, Winter S, et al. Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci USA 1981;78:298-302.
65. Schmid E, Tapscott S, Bennett GS, et al. Differential location of different types of intermediate-sized filaments in various tissues of the chicken embryo. Differentiation 1979;15:27-40.
66. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature 1980;283:249-256.
67. Franke WW, Schmid E, Freudenstein C, et al. Intermediate-sized filaments of the prekeratin type in myoepithelial cells. J Cell Biol 1980;84:633-654.
68. Vandekerckhove J, Weber K. Actin typing on total cellular extracts: A highly sensitive protein-chemical procedure able to distinguish different actins. Eur J Biochem 1981;113:595-603.
69. Chaponnier C, Gabbiani G. Pathological situations characterized by altered actin isoform expression. J Pathol 2004;204:386-395.
70. Hennessey ES, Drummond DR, Sparrow JC, Molecular genetics of actin function. Biochem J 1993;291(Pt 3):657-671.
71. Miwa T, Manabe Y, Kurokawa K, et al. Structure, chromosome location, and expression of the human smooth muscle (enteric type) gamma-actin gene: Evolution of six human actin genes. Mol Cell Biol 1991;11:3296-3306.
72. Tondeleir D, Vandamme D, Vandekerckhove J, et al. Actin isoform expression patterns during mammalian development and in pathology: Insights from mouse models. Cell Motil Cytoskeleton 2009;66:798-815.
73. Schürch W, Bochaton-Piallat ML, Geinoz A, et al. All histological types of primary human rhabdomyosarcoma express alpha- cardiac and not alpha-skeletal actin messenger RNA. Am J Pathol 1994;144:836-846.
74. Dugina V, Zwaenepoel I, Gabbiani G, et al. Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. J Cell Sci 2009;122:2980-2988.
75. Skalli O, Bloom WS, Ropraz P, et al. Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: Relationships to culture conditions and analogies to in vivo situations. J Submicrosc Cytol 1986;18:481-493.
76. Skalli O, Pelte MF, Peclet MC, et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem 1989;37:315-321.
77. Zimmermann KW. Der Feine Bau der Blutkapillaren. Z Anat Entwicklungsgesch 1923;68:29-109.
78. Nehls V, Drenckhahn D. Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol 1991;113:147-154.
79. Kapanci Y, Ribaux C, Chaponnier C, et al. Cytoskeletal features of alveolar myofibroblasts and pericytes in normal human and rat lung. J Histochem Cytochem 1992;40:1955-1963.
80. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3:349-363.
81. Chiavegato A, Bochaton-Piallat ML, D'Amore E, et al. Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia. Virchows Arch 1995;426:77-86.
82. Malmstrom J, Lindberg H, Lindberg C, et al. Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics 2004;3:466-477.
83. Chambers RC, Leoni P, Kaminski N, et al. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 2003;162:533-546.
84. van der Loop FT, Gabbiani G, Kohnen G, et al. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol 1997;17:665-671.
85. Christen T, Verin V, Bochaton-Piallat M, et al. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation 2001;103:882-888.
86. van der Loop FT, Schaart G, Timmer ED, et al. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 1996;134:401-411.
87. Loreal O, Clement B, Deugnier Y. Hepatic fibrogenesis). Rev Prat 1997;47:482-486.
88. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007;127:526-537.
89. Sommer P, Gleyzal C, Raccurt M, et al. Transient expression of lysyl oxidase by liver myofibroblasts in murine schistosomiasis. Lab Invest 1993;69:460-470.
90. Volk SW, Wang Y, Mauldin EA, et al. Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing. Cells Tissues Organs 2011;194(1):25-37.
91. Lagacé R, Grimaud JA, Schürch W, et al. Myofibroblastic stromal reaction in carcinoma of the breast: Variations of collagenous matrix and structural glycoproteins. Virchows Arch A Pathol Anat Histopathol 1985;408:49-59.
92. Barsky SH, Rao CN, Grotendorst GR, et al. Increased content of Type V Collagen in desmoplasia of human breast carcinoma. Am J Pathol 1982;108:276-283.
93. Wessells NK, Spooner BS, Ash JF, et al. Microfilaments in cellular and developmental processes. Science 1971;171:135-143.
94. Madden JW, Morton D Jr, Peacock EE Jr. Contraction of experimental wounds. I. Inhibiting wound contraction by using a topical smooth muscle antagonist. Surgery 1974;76:8-15.
95. Irlé C, Kocher O, Gabbiani G. Contractility of myofibroblasts during experimental liver cirrhosis. Submicrosc Cytol Pathol 1980;12:209-217.
96. Evans JN, Kelley J, Low RB, et al. Increased contractility of isolated lung parenchyma in an animal model of pulmonary fibrosis induced by bleomycin. Am Rev Respir Dis 1982;125:89-94.
97. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
98. Appleton I, Tomlinson A, Chander CL, et al. Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study. Lab Invest 1992;67:703-710.
99. Hahn AW, Resink TJ, Kern F, et al. Effects of endothelin-1 on vascular smooth muscle cell phenotypic differentiation. J Cardiovasc Pharmacol 1992;20(suppl 12):S33-S36.
100. Desmoulière A, Rubbia-Brandt L, Abdiu A, et al. Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res 1992;201:64-73.
101. Vande Berg JS, Rudolph R, Woodward M. Comparative growth dynamics and morphology between cultured myofibroblasts from granulating wounds and dermal fibroblasts. Am J Pathol 1984;114:187-200.
102. Vande Berg JS, Rudolph R, Poolman WL, et al. Comparative growth dynamics and actin concentration between cultured human myofibroblasts from granulating wounds and dermal fibroblasts from normal skin. Lab Invest 1989;61:532-538.
103. Germain L, Jean A, Auger FA, et al. Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. J Surg Res 1994;57:268-273.
104. Azzarone B, Failly-Crepin C, Daya-Grosjean L, et al. Abnormal behavior of cultured fibroblasts from nodule and nonaffected aponeurosis of Dupuytren's disease. J Cell Physiol 1983;117:353-361.
105. Dugina V, Alexandrova A, Chaponnier C, et al. Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp Cell Res 1998;238:481-490.
106. Schmitt-Gräff A, Desmoulière A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: An example of fibroblastic cell plasticity. Virchows Arch 1994;425:3-24.
107. Chang HY, Chi JT, Dudoit S, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002;99:12877-12882.
108. Rinn JL, Bondre C, Gladstone HB, et al. Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet 2006;2:e119.
109. Schmitt-Gräff A, Pau H, Spahr R, et al. Appearance of alpha-smooth muscle actin in human eye lens cells of anterior capsular cataract and in cultured bovine lens-forming cells. Differentiation 1990;43:115-122.
110. Rønnov-Jessen L, van Deurs B, Celis JE, et al. Smooth muscle differentiation in cultured human breast gland stromal cells. Lab Invest 1990;63:532-543.
111. Rockey DC, Friedman SL. Cytoskeleton of liver perisinusoidal cells (lipocytes) in normal and pathological conditions. Cell Motil Cytoskeleton 1992;22:227-234.
112. Elger M, Drenckhahn D, Nobiling R, et al. Cultured rat mesangial cells contain smooth muscle alpha-actin not found in vivo. Am J Pathol 1993;142:497-509.
113. Skalli O, Ropraz P, Trzeciak A, et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986;103:2787-2796.
114. Isenberg G, Rathke PC, Hulsmann N, et al. Cytoplasmic actomyosin fibrils in tissue culture cells: Direct proof of contractility by visualization of ATP-induced contraction in fibrils isolated by laser micro-beam dissection. Cell Tissue Res 1976;166:427-443.
115. Kreis TE, Birchmeier W. Stress fiber sarcomeres of fibroblasts are contractile. Cell 1980;22:555-561.
116. Hinz B. Masters and servants of the force: The role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol 2006;85:175-181.
117. Chrzanowska Wodnicka M, Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 1996;133:1403-1415.
118. Grinnell F, Petroll WM. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev Biol 2010;26:335-361.
119. Mochitate K, Pawelek P, Grinnell F. Stress relaxation of contracted collagen gels: Disruption of actin filament bundles, release of cell surface fibronectin, and down-regulation of DNA and protein synthesis. Exp Cell Res 1991;193:198-207.
120. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870.
121. Hinz B. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: Implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep 2009;11:120-126.
122. Hinz B, Dugina V, Ballestrem C, et al. Alpha-smooth muscle actin Is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell 2003;14:2508-2519.
123. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur J Cell Biol 2008;87:601-615.
124. Georges PC, Hui JJ, Gombos Z, et al. Increased stiffness of the rat liver precedes matrix deposition: Implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007;293:G1147-G1154.
125. Barker HE, Chang J, Cox TR, et al. LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution. Cancer Res 2011;71:1561-1572.
126. Bogatkevich GS, Tourkina E, Abrams CS, et al. Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol 2003;285:L334-L343.
127. Shi-Wen X, Chen Y, Denton CP, et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 2004;15:2707-2719.
128. Rubbia-Brandt L, Sappino AP, Gabbiani G. Locally applied GM-CSF induces the accumulation of alpha-smooth muscle actin containing myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;60:73-82.
129. Kohan M, Muro AF, White ES, Berkman N. EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling. FASEB J 2010;24:4503-4512.
130. Wells RG, Discher DE. Matrix Elasticity, Cytoskeletal Tension, and TGF-β: The Insoluble and Soluble Meet. Sci Signal 2008;1:pe13.
131. Micera A, Vigneti E, Pickholtz D, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98:6162-6167.
132. Harris AK, Stopak D, Wild P. Fibroblast traction as a mechanism for collagen morphogenesis. Nature 1981;290:249-251.
133. Beningo KA, Wang YL. Flexible substrata for the detection of cellular traction forces. Trends Cell Biol 2002;12:79-84.
134. Pfitzer G. Invited review: Regulation of myosin phosphorylation in smooth muscle. J Appl Physiol 2001;91:497-503.
135. Katoh K, Kano Y, Amano M, et al. Rho-kinase-mediated contraction of isolated stress fibers. J Cell Biol 2001;153:569-584.
136. Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996;273:245-248.
137. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003;83:1325-1358.
138. Follonier Castella L, Gabbiani G, McCulloch CA. et al. Regulation of myofibroblast activities: Calcium pulls some strings behind the scene. Exp Cell Res 2010;316:2390-2401.
139. Tomasek JJ, Vaughan MB, Kropp BP, et al. Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity. Wound Repair Regen 2006;14:313-320.
140. Yee HF Jr, Melton AC, Tran BN. RhoA/rho-associated kinase mediates fibroblast contractile force generation. Biochem Biophys Res Commun 2001;280:1340-1345.
141. Emmert DA, Fee JA, Goeckeler ZM, et al. Rho-kinase-mediated Ca2+-independent contraction in rat embryo fibroblasts. Am J Physiol Cell Physiol 2004;286:C8-C21.
142. Nobe H, Nobe K, Fazal F, et al. Rho kinase mediates serum-induced contraction in fibroblast fibers independent of myosin LC20 phosphorylation. Am J Physiol Cell Physiol 2003;284:C599-606.
143. Parizi M, Howard EW, Tomasek JJ. Regulation of LPA-promoted myofibroblast contraction: Role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Exp Cell Res 2000;254:210-220.
144. Follonier Castella L, Buscemi L, Godbout C, et al. A new lock-step mechanism of matrix remodelling based on subcellular contractile events. J Cell Sci 2010;123:1751-1760.
145. Levinson H, Moyer KE, Saggers GC, et al. Calmodulin-myosin light chain kinase inhibition changes fibroblast-populated collagen lattice contraction, cell migration, focal adhesion formation, and wound contraction. Wound Repair Regen 2004;12:505-511.
146. Chilton L, Ohya S, Freed D, et al. K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol 2005;288:H2931-H2939.
147. Raizman JE, Komljenovic J, Chang R, et al. The participation of the Na+-Ca2+ exchanger in primary cardiac myofibroblast migration, contraction, and proliferation. J Cell Physiol 2007;213:540-551.
148. Kernochan LE, Tran BN, Tangkijvanich P, et al. Endothelin-1 stimulates human colonic myofibroblast contraction and migration. Gut 2002;50:65-70.
149. Laleman W, Van Landeghem L, Severi T, et al. Both Ca2+ dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine. Am J Physiol Gastrointest Liver Physiol 2007;292:G556-G564.
150. Kawada N, Tran-Thi TA, Klein H, et al. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993;213:815-823.
151. Pinzani M, Failli P, Ruocco C, et al. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 1992;90:642-646.
152. Geiger B, Bershadsky A, Pankov R, et al. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2001;2:793-805.
153. Dugina V, Fontao L, Chaponnier C, et al. Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci 2001;114:3285-3296.
154. Cukierman E, Pankov R, Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002;14:633-639.
155. Willingham MC, Yamada SS, Davies PJ, et al. Intracellular localization of actin in cultured fibroblasts by electron microscopic immunocytochemistry. J Histochem Cytochem 1981;29:17-37.
156. Rønnov-Jessen L, Petersen OW. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts. J Cell Biol 1996;134:67-80.
157. Pittet P, Lee K, Kulik AJ, et al. Fibrogenic fibroblasts increase intercellular adhesion strength by reinforcing individual OB-cadherin bonds. J Cell Sci 2008;121:877-886.
158. El Sayegh TY, Kapus A, McCulloch CA. Beyond the epithelium: Cadherin function in fibrous connective tissues. FEBS Lett 2007;581:167-174.
159. Tomita K, van Bokhoven A, van Leenders GJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-3654.
160. Shibata T, Ochiai A, Gotoh M, et al. Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer. Cancer Lett 1996;99:147-153.
161. Roosen A, Apostolidis A, Elneil S, et al. Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts. J Urol 2009;182:190-195.
162. Follonier L, Schaub S, Meister JJ, et al. Myofibroblast communication is controlled by intercellular mechanical coupling. J Cell Sci 2008;121:3305-3316.
163. O'Shea JD. An ultrastructural study of smooth muscle-like cells in the theca externa of ovarian follicles in the rat. Anat Rec 1970;167:127-131.
164. Boya J, Carbonell AL, Martinez A. Myofibroblasts in human palatal mucosa. Acta Anat Basel 1988;131:161-165.
165. Guldner FH, Wolff JR, Keyserlingk DG. Fibroblasts as a part of the contractile system in duodenal villi of rat. Z Zellforsch Mikrosk Anat 1972;135:349-360.
166. Kaye GI, Lane N, Pascal RR. Colonic pericryptal fibroblast sheath: Replication, migration, and cytodifferentiation of a mesenchymal cell system in adult tissue. II. Fine structural aspects of normal rabbit and human colon. Gastroenterology 1968;54:852-865.
167. Bressler RS. Myoid cells in the capsule of the adrenal gland and in monolayers derived from cultured adrenal capsules. Anat Rec 1973;177:525-531.
168. Kapanci Y, Assimacopoulos A, Irlé C, et al. "Contractile interstitial cells" in pulmonary alveolar septa: a possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluorescence, and in vitro studies. J Cell Biol 1974;60:375-392.
169. Gorgas K, Bock P. Myofibroblasts in the rat testicular capsule. Cell Tissue Res 1974;154:533-541.
170. Czernobilsky B, Shezen E, Lifschitz-Mercer B, et al. Alpha smooth muscle actin (alpha-SM actin) in normal human ovaries, in ovarian stromal hyperplasia and in ovarian neoplasms. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;57:55-61.
171. Parry EW. Some electron microscope observations on the mesenchymal structures of full-term umbilical cord. J Anat 1970;107:505-518.
172. Tabone E, Andujar MB, De Barros SS, et al. Myofibroblast-like cells in non-pathological bovine endometrial caruncle. Cell Biol Int Rep 1983;7:395-400.
173. Beertsen W, Everts V, van den Hooff A. Fine structure of fibroblasts in the periodontal ligament of the rat incisor and their possible role in tooth eruption. Arch Oral Biol 1974;19:1087-1098.
174. Beertsen W. Migration of fibroblasts in the periodontal ligament of the mouse incisor as revealed by autoradiography. Arch Oral Biol 1975;20:659-666.
175. Toccanier-Pelté MF, Skalli O, Kapanci Y, et al. Characterization of stromal cells with myoid features in lymph nodes and spleen in normal and pathologic conditions. Am J Pathol 1987;129:109-118.
176. Yokoi Y, Namihisa T, Kuroda H, et al. Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 1984;4:709-714.
177. Glasser SR, Julian J. Intermediate filament protein as a marker of uterine stromal cell decidualization. Biol Reprod 1986;35:463-474.
178. Charbord P, Lerat H, Newton I, et al. The cytoskeleton of stromal cells from human bone marrow cultures resembles that of cultured smooth muscle cells. Exp Hematol 1990;18:276-282.
179. Becker CG. Demonstration of actomyosin in mesangial cells of the renal glomerulus. Am J Pathol 1972;66:97-110.
180. Desmoulière A, Gabbiani G. Modulation of fibroblastic cytoskeletal features during pathological situations: the role of extracellular matrix and cytokines, Cell Motil. Cytoskeleton 1994;29:195-203.
181. Sappino AP, Schürch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63:144-161.
182. Eyden BP, Ponting J, Davies H, et al. Defining the myofibroblast: Normal tissues, with special reference to the stromal cells of Wharton's jelly in human umbilical cord. J Submicrosc Cytol Pathol 1994;26:347-355.
183. Rudolph R, Guber S, Suzuki M, et al. The life cycle of the myofibroblast. Surg Gynecol Obstet 1977;145:389-394.
184. Gabbiani G, Le Lous M, Bailey AJ, et al. Collagen and myofibroblasts of granulation tissue. A chemical, ultrastructural and immunologic study. Virchows Arch B Cell Pathol 1976;21;133-145.
185. Burrington JD. Wound healing in the fetal lamb. J Pediatr Surg 1971;6:523-528.
186. Rowsell AR. The intra-uterine healing of foetal muscle wounds: Experimental study in the rat. Br J Plast Surg 1984;37:635-642.
187. Adzick NS, Longaker MT. Scarless fetal healing. Therapeutic implications. Ann Surg 1992;215:3-7.
188. Estes JM, Vande Berg JS, Adzick NS, et al. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994;56:173-181.
189. Chakravarti S, Wu F, Vij N, et al. Microarray studies reveal macrophage-like function of stromal keratocytes in the cornea. Invest Ophthalmol Vis Sci 2004;45:3475-3484.
190. Pei Y, Sherry DM, McDermott AM. Thy-1 distinguishes human corneal fibroblasts and myofibroblasts from keratocytes. Exp Eye Res 2004;79;705-712.
191. Seemayer TA, Schürch W, Lagacé R. Myofibroblasts in human pathology. Hum Pathol 1981;12:491-492.
192. Cassiman D, Libbrecht L, Desmet V, et al. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002;36:200-209.
193. Rudolph R, McClure WJ, Woodward M. Contractile fibroblasts in chronic alcoholic cirrhosis. Gastroenterology 1979;76:704-709.
194. Madden JW. On "the contractile fibroblast". Plast Reconstr Surg 1973;52:291-292.
195. Woyke S, Domagala W, Olszewski W, et al. Pseudosarcoma of the skin. An electron microscopic study and comparison with the fine structure of spindle-cell variant of squamous carcinoma. Cancer 1974;33:970-980.
196. Larson DL, Abston S, Willis B, et al. Contracture and scar formation in the burn patient. Clin Plast Surg 1974;1:653-656.
197. Madden JW, Carlson EC, Hines J. Presence of modified fibroblasts in ischemic contracture of the intrinsic musculature of the hand. Surg Gynecol Obstet 1975;140:509-516.
198. Nagle RB, Kneiser MR, Bulger RE, et al. Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy. Lab Invest 1973;29:422-427.
199. Judd PA, Finnegan P, Curran RC. Pulmonary sarcoidosis: A clinico-pathological study. J Pathol 1975;115:191-198.
200. El-Labban NG, Lee KW. Myofibroblasts in central giant cell granuloma of the jaws: An ultrastructural study. Histopathology 1983;7:907-918.
201. Grimaud JA, Borojevic R. Myofibroblasts in hepatic schistosomal fibrosis. Experientia 1977;33:890-892.
202. Postacchini F, Natali PG, Accinni L, et al. Contractile filaments in cells of regenerating tendon. Experientia 1977;33:957-959.
203. Rudolph R, Abraham J, Vecchione T, et al. Myofibroblasts and free silicon around breast implants. Plast Reconstr Surg 1978;62:185-196.
204. Callea F, Mebis J, Desmet VJ. Myofibroblasts in focal nodular hyperplasia of the liver. Virchows Arch A Pathol Anat Histol 1982;396:155-166.
205. Ghadially FN, Mehta PN. Multifunctional mesenchymal cells resembling smooth muscle cells in ganglia of the wrist. Ann Rheum Dis 1971;30:31-42.
206. Baur PS, Larson DL, Stacey TR. The observation of myofibroblasts in hypertrophic scars. Surg Gynecol Obstet 1975;141:22-26.
207. Novotny GE, Pau H. Myofibroblast-like cells in human anterior capsular cataract. Virchows Arch A Pathol Anat Histopathol 1984;404:393-401.
208. Woodcock-Mitchell J, Adler KB, Low RB. Immunohistochemical identification of cell types in normal and in bleomycin-induced fibrotic rat lung. Cellular origins of interstitial cells. Am Rev Respir Dis 1984;130:910-916.
209. Lagacé R, Delage C, Boutet M. Light and electron microscopic study of cellular proliferation in carcinoid heart disease. Recent Adv Stud Cardiac Struct Metab 1975;10:605-616.
210. Thomas WA, Jones R, Scott RF, et al. Production of early atherosclerotic lesions in rats characterized by proliferation of "modified smooth muscle cells". Exp Mol Pathol 1963;52:(suppl 1):40-61.
211. Flora G, Dahl E, Nelson E. Electron microscopic observations on human intracranial arteries. Changes seen with aging and atherosclerosis. Arch Neurol 1967;17:162-173.
212. Wissler RW. The arterial medial cell, smooth muscle, or multifunctional mesenchyme? Circulation 1967;36:1-4.
213. Sappino AP, Masouye I, Saurat JH, et al. Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol 1990;137:585-591.
214. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003;23:1510-1520.
215. Hao H, Gabbiani G, Camenzind E, et al. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vasc Biol 2006;26:326-332.
216. Diamond JR, van Goor H, Ding G, et al. Myofibroblasts in experimental hydronephrosis. Am J Pathol 1995;146:121-129.
217. Desmoulière A, Gabbiani G. The role of myofibroblasts in wound healing and fibrocontractive diseases. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. 2nd ed. New York, NY: Plenum Press; 1996:391-423.
218. Schürch W, Seemayer TA, Gabbiani G. Myofibroblasts. In: Sternberg SS, ed. Histology for Pathologists. New York, NY: Raven Press; 1992:109-144.
219. Ehrlich HP, Desmoulière A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994;145:105-113.
220. Gizycki MJ, Adelroth E, Rogers AV, et al. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997;16:664-673.
221. Santucci M, Borgognoni L, Reali UM, et al. Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch 2001;438:457-463.
222. Gabbrielli S, Di Lollo S, Stanflin N, et al. Myofibroblast and elastic and collagen fiber hyperplasia in the bronchial mucosa: a possible basis for the progressive irreversibility of airway obstruction in chronic asthma. Pathologica 1994;86:157-160.
223. Hastie AT, Kraft WK, Nyce KB, et al. Asthmatic epithelial cell proliferation and stimulation of collagen production: human asthmatic epithelial cells stimulate collagen type III production by human lung myofibroblasts after segmental allergen challenge. Am J Respir Crit Care Med 2002;165:266-272.
224. Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev Orlando 2008;22:1-5.
225. Kizu A, Medici D, Kalluri R. Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol 2009;175(4):1371-1373.
226. Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 2011.
227. Li J, Deane JA, Campanale NV, et al. The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 2007;25:697-706.
228. Bariéty J. La biopsie rénale dans la hyalinose segmentaire et focale des glomérules. In: Droz D, Lanz B. eds. La biopsie rénale. Paris: Editions INSERM; 1996:109-134.
229. Hills CE, Squires PE. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol 2010;31:68-74.
230. Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 2009;175(4):1380-1388.
231. Enzinger FM, Weiss SW. Fibromatoses. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors. St. Louis: Mosby; 1994:201-229.
232. Meister P, Gokel JM, Remberger K. Palmar fibromatosis-"Dupuytren's contracture". A comparison of light electron and immunofluorescence microscopic findings. Pathol Res Pract 1979;164:402-412.
233. Chiu HF, McFarlane RM. Pathogenesis of Dupuytren's contracture: A correlative clinical-pathological study. J Hand Surg Am 1978;3:1-10.
234. Navas-Palacios JJ. The fibromatoses. An ultrastructural study of 31 cases. Pathol Res Pract 1983;176:158-175.
235. Ushijima M, Tsuneyoshi M, Enjoji M. Dupuytren type fibromatoses. A clinicopathologic study of 62 cases. Acta Pathol Jpn 1984;34:991-1001.
236. Allen PW. The fibromatoses: A clinicopathologic classification based on 140 cases. Am J Surg Pathol 1977;1:255-270.
237. Chung EB, Enzinger FM. Infantile myofibromatosis. Cancer 1981;48:1807-1818.
238. Wirman JA. Nodular fasciitis, a lesion of myofibroblasts: An ultrastructural study. Cancer 1976;38:2378-2389.
239. Chung EB, Enzinger FM. Proliferative fasciitis. Cancer 1975;36:1450-1458.
240. Povysil C, Matejovsky Z. Ultrastructural evidence of myofibroblasts in pseudomalignant myositis ossificans. Virchows Arch A Pathol Anat Histol 1979;381:189-203.
241. Weathers DR, Campbell WG. Ultrastructure of the giant-cell fibroma of the oral mucosa. Oral Surg Oral Med Oral Pathol 1974;38:550-561.
242. Stiller D, Katenkamp D. Cellular features in desmoid fibromatosis and well-differentiated fibrosarcomas: An electron microscopic study. Virchows Arch A Pathol Anat Histol 1975;369:155-164.
243. Ramos CV, Gillespie W, Narconis RJ. Elastofibroma. A pseudotumor of myofibroblasts. Arch Pathol Lab Med 1978;102:538-540.
244. Buell R, Wang NS, Seemayer TA, et al. Endobronchial plasma cell granuloma (xanthomatous pseudotumor); a light and electron microscopic study. Hum Pathol 1976;7:411-426.
245. Bhawan J, Bacchetta C, Joris I, et al. A myofibroblastic tumor. Infantile digital fibroma (recurrent digital fibrous tumor of childhood). Am J Pathol 1979;94:19-36.
246. Taxy JB. Juvenile nasopharyngeal angiofibroma: An ultrastructural study. Cancer 1977;39:1044-1054.
247. Ferrans VJ, Roberts WC. Structural features of cardiac myxomas. Histology, histochemistry, and electron microscopy. Hum Pathol 1973;4:111-146.
248. Fisher ER, Paulson JD, Gregorio RM. The myofibroblastic nature of the uterine plexiform tumor. Arch Pathol Lab Med 1978;102:477-480.
249. Tomasek JJ, Schultz RJ, Episalla CW, et al. The cytoskeleton and extracellular matrix of the Dupuytren's disease "myofibroblast": An immunofluorescence study of a nonmuscle cell type. J Hand Surg Am 1986;11:365-371.
250. Shum DT, McFarlane RM. Histogenesis of Dupuytren's disease: An immunohistochemical study of 30 cases. J Hand Surg Am 1988;13:61-67.
251. Schürch W, Bégin LR, Seemayer TA, et al. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am J Surg Pathol 1996;20:131-147.
252. Luck JV. Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959;41A:635-664.
253. Iwasaki H, Muller H, Stutte HJ, et al. Palmar fibromatosis (Dupuytren's contracture). Ultrastructural and enzyme histochemical studies of 43 cases. Virchows Arch A Pathol Anat Histopathol 1984;405:41-53.
254. Eddy RJ, Petro JA, Tomasek JJ. Evidence for the nonmuscle nature of the "myofibroblast" of granulation tissue and hypertropic scar. An immunofluorescence study. Am J Pathol 1988;130:252-260.
255. Matte C, Cadotte M, Schürch W. Intermediate filament proteins and actin isoforms of dermatofibrosarcoma protuberans and dermatofibroma. Lab Invest 1990;62:64A.
256. Fukasawa Y, Ishikura H, Takada A, et al. Massive apoptosis in infantile myofibromatosis. A putative mechanism of tumor regression. Am J Pathol 1994;144:480-485.
257. Hinz B, Desmoulière A, Darby IA, et al. The role of the myofibroblast in fibrosis and cancer progression. In: Fusenig MMMN, ed. Tumor-Associated Fibroblasts and Their Matrix. Springer Dodrecht Heidelberg; 2011:37-74.
258. Desmoulière A, Darby IA, Gabbiani G. Normal and pathologic soft tissue remodeling: Role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 2003;83:1689-1707.
259. Cintorino M, Bellizzi de Marco E, Leoncini P, et al. Expression of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. Int J Cancer 1991;47:843-846.
260. Schürch W, Seemayer TA, Hinz B, et al. Myofibroblast. In: Mills SE ed. Histology for Pathologists. Philadelphia, PA: Lippincott-Williams & Wilkins Pub; 2007:123-164.
261. Carroll R. The influence of lung scars on primary lung cancer. J Pathol Bacteriol 1962;83:293-297.
262. Madri JA, Carter D. Scar cancers of the lung: origin and significance. Hum Pathol 1984;15:625-631.
263. Barsky SH, Huang SJ, Bhuta S. The extracellular matrix of pulmonary scar carcinomas is suggestive of a desmoplastic origin. Am J Pathol 1986;124:412-419.
264. Micke P, Ostman A. Tumour-stroma interaction: Cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 2004;45(suppl. 2):S163-175.
265. De Wever O, Nguyen QD, Van Hoorde L, et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. Faseb J 2004;18:1016-1018.
266. Hill R, Song Y, Cardiff RD, et al. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 2005;123:1001-1011.
267. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007;7:139-147.
268. Gonda TA, Varro A, Wang TC, et al. Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy? Semin Cell Dev Biol 2009;21(1):2-10.
269. Lagacé R, Schürch W, Seemayer TA. Myofibroblasts in soft tissue sarcomas. Virchows Arch A Pathol Anat Histol 1980;389:1-11.
270. Seemayer TA, Lagacé R, Schürch W. On the pathogenesis of sclerosis and nodularity in nodular sclerosing Hodgkin's disease. Virchows Arch A Pathol Anat Histol 1980;385:283-291.
271. Taccagni G, Rovere E, Masullo M, et al. Myofibrosarcoma of the breast: Review of the literature on myofibroblastic tumors and criteria for defining myofibroblastic differentiation. Am J Surg Pathol 1997;21:489-496.
272. Churg AM, Kahn LB. Myofibroblasts and related cells in malignant fibrous and fibrohistiocytic tumors. Hum Pathol 1977;8:205-218.
273. D'Andiran G, Gabbiani G. A metastasizing sarcoma of the pleura composed of myofibroblasts. In: Fenoglio CM, Woolf CM. eds. Progress in Surgical Pathology. New York, NY: Masson Publishing; 1980:31-40.
274. Eyden BP, Christensen L, Tagore V, et al. Myofibrosarcoma of subcutaneous soft tissue of the cheek. J Submicrosc Cytol Pathol 1992;24:307-313.
275. Mentzel T, Dry S, Katenkamp D, et al. Low-grade myofibroblastic sarcoma: Analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol 1998;22:1228-1238.
276. Eyden BP, Banerjee SS, Harris M, et al. A study of spindle cell sarcomas showing myofibroblastic differentiation. Ultrastruct Pathol 1991;15:367-378.
277. Fisher C. Myofibroblastic malignancies. Adv Anat Pathol 2004;11:190-201.
278. Alobeid B, Beneck D, Sreekantaiah C, et al. Congenital pulmonary myofibroblastic tumor: A case report with cytogenetic analysis and review of the literature. Am J Surg Pathol 1997;21:610-614.
279. Fletcher CD, Tsang WY, Fisher C, et al. Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol 1992;16:373-382.
280. Fukunaga M, Nomura K, Matsumoto K, et al. Vulval angiomyofibroblastoma. Clinicopathologic analysis of six cases. Am J Clin Pathol 1997;107:45-51.
281. Ghadially FN, McNaughton JD, Lalonde JM. Myofibroblastoma: A tumour of myofibroblasts. J Submicrosc Cytol 1983;15:1055-1063.
282. Herrera GA, Johnson WW, Lockard VG, et al. Soft tissue myofibroblastomas. Mod Pathol 1991;4:571-577.
283. Laskin WB, Fetsch JF, Mostofi FK. Angiomyofibroblastomalike tumor of the male genital tract: analysis of 11 cases with comparison to female angiomyofibroblastoma and spindle cell lipoma. Am J Surg Pathol 1998;22:6-16.
284. Ockner DM, Sayadi H, Swanson PE, et al. Genital angiomyofibroblastoma. Comparison with aggressive angiomyxoma and other myxoid neoplasms of skin and soft tissue. Am J Clin Pathol 1997;107:36-44.
285. Prayson RA, Estes ML, McMahon JT, et al. Meningeal myofibroblastoma. Am J Surg Pathol 1993;17:931-936.
286. Suster S, Rosai J. Intranodal hemorrhagic spindle-cell tumor with "amianthoid" fibers. Report of six cases of a distinctive mesenchymal neoplasm of the inguinal region that simulates Kaposi's sarcoma. Am J Surg Pathol 1989;13:347-357.
287. Thomas TM, Myint A, Mak CK, et al. Mammary myofibroblastoma with leiomyomatous differentiation. Am J Clin Pathol 1997;107:52-55.
288. Wargotz ES, Weiss SW, Norris HJ. Myofibroblastoma of the breast. Sixteen cases of a distinctive benign mesenchymal tumor. Am J Surg Pathol 1987;11:493-502.
289. Weiss SW, Gnepp DR, Bratthauer GL. Palisaded myofibroblastoma. A benign mesenchymal tumor of lymph node. Am J Surg Pathol 1989;13:341-346.
290. Bégin LR. Myogenic stromal tumor of the male breast (so-called myofibroblastoma). Ultrastruct Pathol 1991;15:613-622.
291. Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumour. In: Fletcher CD, Unni KK, Mertens F, eds. Pathology and Genetics of Tumors of Soft Tissue and Bone. IARC, Lyon, France: World Health Organization Classification of Tumors; 2002:91-93.
292. O'Brien JE, Stout AP. Malignant Fibrous Xanthomas. Cancer 1964;17:1445-1455.
293. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: A study of 135 cases. Mod Pathol 2002;15:931-938.
294. Eyden B. Electron microscopy in the study of myofibroblastic lesions. Semin Diagn Pathol 2003;20:13-24.
295. Cohnheim J. Ueber Entzundung und Eiterung. Virchows Arch path Anat 1867;40:1-79.
296. Arey LG. Wound healing. Physiol Rev 1936;16:327-406.
297. Grillo HC. Derivation of fibroblasts in the healing wound. Arch Surg 1964;88:218-224.
298. Allgöwer M. The Cellular Basis of Wound Repair. Springfield, IL: Oxford: Blackwell Scientific Publications; 1956.
299. Ross R, Everett NB, Tyler R. Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J Cell Biol 1970;44:645-654.
300. Oda D, Gown AM, Vande Berg JS, et al. The fibroblast-like nature of myofibroblasts. Exp Mol Pathol 1988;49:316-329.
301. Hinz B. The myofibroblast in connective tissue repair and regeneration. In: Ralphs CAJ, ed. Regenerative Medicine and Biomaterials for the Repair of Connective Tissues. Cambridge: Woodhead Publishing Ltd; 2010:39-82.
302. Sundberg C, Ivarsson M, Gerdin B, et al. Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest 1996;74:452-466.
303. Rajkumar VS, Shiwen X, Bostrom M, et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 2006;169:2254-2265.
304. Crocker DJ, Murad TM, Geer JC. Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol 1970;13:51-65.
305. Wong JK, Lui YH, Kapacee Z, et al. The cellular biology of flexor tendon adhesion formation: An old problem in a new paradigm. Am J Pathol 2009;175:1938-1951.
306. Kinner B, Gerstenfeld LC, Einhorn TA, et al. Expression of smooth muscle actin in connective tissue cells participating in fracture healing in a murine model. Bone 2002;30:738-745.
307. Spector M. Musculoskeletal connective tissue cells with muscle: Expression of muscle actin in and contraction of fibroblasts, chondrocytes, and osteoblasts. Wound Repair Regen 2001;9:11-18.
308. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428.
309. Kim KK, Wei Y, Szekeres C, et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009;119:213-224.
310. Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest 2004;84:153-159.
311. Desmoulière A. Hepatic stellate cells: the only cells involved in liver fibrogenesis? A dogma challenged. Gastroenterology 2007;132:2059-2062.
312. Guyot C, Lepreux S, Combe C, et al. Hepatic fibrosis and cirrhosis: The (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006;38:135-151.
313. Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hematol 2010;38:548-556.
314. Wang D, Park JS, Chu JS, et al. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem 2004;279:43725-43734.
315. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006;10:76-99.
316. Moreels M, Vandenabeele F, Dumont D, et al. Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: Potential regulatory role of transforming growth factor-beta 1 (TGF-beta1). Neuropathol Appl Neurobiol 2008;34:532-546.
317. Masszi A, Di Ciano C, Sirokmany G, et al. Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 2003;284:F911-924.
318. Kocher O, Skalli O, Bloom WS, et al. Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest 1984;50:645-652.
319. Chamley JH, Campbell GR, McConnell JD, et al. Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture. Cell Tissue Res 1977;177:503-522.
320. Moss NS, Benditt EP. Spontaneous and experimentally induced arterial lesions. I. An ultrastructural survey of the normal chicken aorta. Lab Invest 1970;22:166-183.
321. Mosse PR, Campbell GR, Wang ZL, et al. Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 1985;53:556-562.
322. Olivetti G, Anversa P, Loud AV. Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations. Circ Res 1980;46:503-512.
323. Babaï F, Musevi-Aghdam J, Schürch W, et al. Coexpression of alpha-sarcomeric actin, alpha-smooth muscle actin and desmin during myogenesis in rat and mouse embryos I. Skeletal muscle, Differentiation 1990;44:132-142.
324. Franke WW, Moll R. Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen. Differentiation 1987;36:145-163.
325. Rønnov-Jessen L, Petersen OW, Koteliansky VE, et al. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995;95:859-873.
326. Boukhalfa G, Desmoulière A, Rondeau E, et al. Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney. Exp Nephrol 1996;4:241-247.
327. Vyalov SL, Gabbiani G, Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 1993; 143:1754-1765.
328. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-890.
329. Masszi A, Speight P, Charbonney E, et al. Fate-determining mechanisms in epithelial-myofibroblast transition: Major inhibitory role for Smad3. J Cell Biol 2010;188:383-399.
330. Humphreys BD, Lin SL, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010;176:85-97.
331. Ramadori G, Veit T, Schwogler S, et al. Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1990;59:349-357.
332. Schmitt-Gräff A, Kruger S, Bochard F, et al. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991;138:1233-1242.
333. Milani S, Herbst H, Schuppan D, et al. Cellular localization of laminin gene transcripts in normal and fibrotic human liver. Am J Pathol 1989;134:1175-1182.
334. Milani S, Herbst H, Schuppan D, et al. Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver. Am J Pathol 1990;137:59-70.
335. Rubbia-Brandt L, Mentha G, Desmoulière A, et al. Hepatic stellate cells reversibly express alpha-smooth muscle actin during acute hepatic ischemia. Transplant Proc 1997;29:2390-2395.
336. Greenbaum LE, Wells RG. The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol 2011;43:222-229.
337. Forbes SJ, Russo FP, Rey V, et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004;126:955-963.
338. Kisseleva T, Uchinami H, Feirt N, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:429-438.
339. Mori L, Bellini A, Stacey MA, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005;304:81-90.
340. Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 2006;8:145-150.
341. Schmidt M, Sun G, Stacey MA, et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003;171:380-389.
342. Ishii G, Sangai T, Sugiyama K, et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 2005;23:699-706.
343. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438-446.
344. Sakai N, Wada T, Yokoyama H, et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006;103:14098-14103.
345. Haudek SB, Xia Y, Huebener P, et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A 2006;103:18284-18289.
346. Andersson-Sjoland A, de Alba CG, Nihlberg K, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008;40:2129-2140.
347. Wada T, Sakai N, Matsushima K, et al. Fibrocytes: A new insight into kidney fibrosis. Kidney Int 2007;72:269-273.
348. Frid MG, Brunetti JA, Burke DL, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 2006;168:659-669.
349. Varcoe RL, Mikhail M, Guiffre AK, et al. The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost 2006;4:1125-1133.
350. Direkze NC, Hodivala-Dilke K, Jeffery R, et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004;64:8492-8495.
351. Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009;179:588-594.
352. Wang CH, Huang CD, Lin HC, et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 2008;178:583-591.
353. Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow-derived cells to skin: Collagen deposition and wound repair. Stem Cells 2004;22:812-822.
354. Fujita J, Mori M, Kawada H, et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells 2007;25:2750-2759.
355. Schmitt-Gräff A, Skalli O, Gabbiani G. Alpha-smooth muscle actin is expressed in a subset of bone marrow stromal cells in normal and pathological conditions. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;57:291-302.
356. Yokota T, Kawakami Y, Nagai Y, et al. Bone marrow lacks a transplantable progenitor for smooth muscle type alpha-actin-expressing cells. Stem Cells 2006;24:13-22.
357. Roufosse CA, Direkze NC, Otto WR, et al. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 2004;36:585-597.
358. Skalli O, Gabbiani G. The biology of the myofibroblast relationship to wound contraction and fibrocontractive diseases. In: Clark RAF, Henson PM, eds. The Molecular and Cellular Biology of Wound Repair. New York, NY: Plenum Press; 1988:373-402.
359. Holgate ST, Davies DE, Lackie PM, et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000;105:193-204.
360. Garbin S, Pittet B, Montandon D, et al. Covering by a flap induces apoptosis of granulation tissue myofibroblasts and vascular cells. Wound Repair Regen 1996;4:244-251.
361. Carlson MA, Longaker MT, Thompson JS. Granulation tissue regression induced by musculocutaneous advancement flap coverage. Surgery 2002;131:332-337.
362. Grinnell F, Zhu M, Carlson MA, et al. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res 1999;248:608-619.
363. Douglass A, Wallace K, Parr R, et al. Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. J Hepatol 2008;49:88-98.
364. Evans VG. Multiple pathways to apoptosis. Cell Biol Int 1993;17:461-476.
365. Lee S, Christakos S, Small MB. Apoptosis and signal transduction: Clues to a molecular mechanism. Curr Opin Cell Biol. 1993;5:286-291.
366. Schwartzman RA, Cidlowski JA. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 1993;14:133-151.
367. White E. Death-defying acts: A meeting review on apoptosis. Genes Dev. 1993;7:2277-2284.
368. Williams GT, Smith CA. Molecular regulation of apoptosis: Genetic controls on cell death. Cell 1993;74:777-779.
369. Martin SJ, Green DR, Cotter TG. Dicing with death: Dissecting the components of the apoptosis machinery. Trends Biochem Sci 1994;19:26-30.
370. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:19-128.
371. Miura M, Zhu H, Rotello R, et al. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993;75:653-660.
372. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
373. Horowitz JC, Rogers DS, Sharma V, et al. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 2007;19:761-771.
374. de Andrade JA, Thannickal VJ. Innovative approaches to the therapy of fibrosis. Curr Opin Rheumatol 2009;21(6):649-655.
375. Kulasekaran P, Scavone CA, Rogers DS, et al. Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. Am J Respir Cell Mol Biol 2009;41:484-493.
376. Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 1988;141:2629-2634.
377. Moulton BC. Transforming growth factor-beta stimulates endometrial stromal apoptosis in vitro. Endocrinology 1994;134:1055-1060.
378. Pierce GF, Mustoe TA, Senior RM, et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1988;167:974-987.
379. Novo E, di Bonzo LV, Cannito S, et al. Hepatic myofibroblasts: A heterogeneous population of multifunctional cells in liver fibrogenesis. Int J Biochem Cell Biol 2009;41:2089-2093.
380. Hecker L, Jagirdar R, Jin T, et al. Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res 2011;317(13):1914-1921.
381. Streuli CH, Schmidhauser C, Kobrin M, et al. Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol 1993;120:253-260.
382. Peyrol S, Raccourt F, Gerard F, Gleyzal C, Grimaud JA, Sommer P. Lysil oxidase gene expression in the stroma reaction to in situ and invasive ductal breast carcinoma. Am J Pathol 1997;150(2):497-507.
383. Doljanski F. The sculpturing role of fibroblast-like cells in morphogenesis. Perspect Biol Med 2004;47:339-356.
384. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121:335-348.
385. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-1659.